Greater Noida, February 2026:
The Yamuna Expressway Industrial Development Authority (YEIDA) has taken a major step toward strengthening India’s position as a global hub for medical device manufacturing by initiating collaboration with Accuprec Research Labs, a leading NABL-accredited testing agency. The partnership focuses on establishing internationally compliant testing infrastructure within the Medical Devices Park in Sector 28, aimed at enabling manufacturers to meet global regulatory requirements efficiently and competitively.
The initiative emerged from strategic discussions held during the WHX Dubai summit, where YEIDA officials and Accuprec representatives explored opportunities to create world-class laboratory infrastructure within the medical devices ecosystem being developed along the Yamuna Expressway. The proposed collaboration will center on setting up laboratories compliant with the Accreditation Scheme for Conformity Assessment (ASCA), a globally recognized framework that ensures testing data meets international regulatory standards, including those accepted by the United States Food and Drug Administration (USFDA).
Officials stated that integrating ASCA-certified laboratories within the Medical Devices Park will significantly benefit manufacturers by enabling product testing and certification at the source. This will reduce the need to send products abroad for compliance verification, thereby lowering costs, accelerating regulatory approvals, and improving the competitiveness of Indian medical device manufacturers in global markets.
Following the initial meeting between Accuprec Director Manish Rachchh and a senior YEIDA delegation in Dubai, Accuprec’s technical team conducted a comprehensive site visit to the Yamuna Authority’s Medical Devices Park to assess existing infrastructure and evaluate technical requirements for establishing advanced testing facilities. The visit was led by Shailendra Kumar Bhatia, IAS, Additional Chief Executive Officer of YEIDA, along with Praveen Kumar Mittal, Executive Director of the Export Promotion Council, and officials from YEIDA’s project department.
During the visit, technical consultants from EY delivered a detailed presentation outlining the Common Scientific Facilities (CSF) planned for the park. The presentation included information on advanced testing equipment currently being procured and the design framework intended to support medical device manufacturers operating within the industrial zone. Officials emphasized that the CSF will provide shared access to high-end scientific infrastructure, enabling both established companies and emerging manufacturers to conduct essential product testing without investing individually in costly laboratory systems.
Accuprec’s technical team also conducted a physical walkthrough and infrastructure audit of the upcoming facilities. The assessment focused on ensuring that the laboratory design integrates effectively with the park’s existing utilities, engineering systems, and industrial layout. This evaluation is critical to ensuring seamless operational integration once the laboratories become functional.
As part of the collaboration, Accuprec has proposed a dual-phase hybrid investment strategy designed to accelerate the operational readiness of the testing ecosystem. The first component involves upgrading existing infrastructure through a brownfield development approach. Under this phase, Accuprec will enhance and manage the Common Scientific Facilities to meet ASCA certification requirements and international regulatory benchmarks. This will allow the facilities to begin supporting manufacturers in the near term while ensuring compliance with global testing standards.
The second component involves greenfield development, which will focus on designing and constructing new specialized testing modules for medical device categories not currently covered by existing infrastructure. These facilities will include advanced laboratories tailored to specific testing requirements, ensuring comprehensive support for a wide range of medical technologies, including diagnostic equipment, implantable devices, and electronic medical systems.
Officials stated that the hybrid investment model is intended to balance immediate operational readiness with long-term expansion. By upgrading existing facilities while simultaneously building new infrastructure, the Medical Devices Park will be able to support manufacturers at different stages of development and across diverse product categories.
Shailendra Kumar Bhatia emphasized the strategic importance of integrating ASCA-certified testing capabilities within the Medical Devices Park. He stated that establishing globally recognized testing facilities at the source will ensure that medical devices manufactured in the park meet the highest international quality standards. This development is expected to enhance the credibility of products manufactured within the park and improve their acceptance in international markets.
Both YEIDA and Accuprec have agreed on a one-month timeline for completing a detailed technical feasibility study. The study will identify specific equipment requirements, laboratory layouts, operational workflows, and investment plans for both brownfield upgrades and greenfield construction. The report will serve as the foundation for finalizing implementation timelines and investment commitments.
Officials noted that YEIDA’s Medical Devices Park is one of Uttar Pradesh’s flagship industrial projects aimed at building a comprehensive ecosystem for the medical technology sector. The park is designed to provide integrated infrastructure, including manufacturing zones, testing facilities, research support, and regulatory compliance services. By offering shared scientific and technical resources, the park aims to reduce entry barriers for medical device manufacturers and encourage domestic and international investment.
The collaboration with Accuprec Research Labs is expected to strengthen the park’s technical capabilities and enhance its attractiveness to global manufacturers seeking reliable and internationally compliant testing infrastructure. Accuprec, headquartered in Ahmedabad, is a leading contract research organization providing testing services for pharmaceutical and medical device companies. The company holds multiple national and international accreditations and has extensive experience supporting regulatory compliance and product validation.
Authorities stated that the development of ASCA-certified laboratories will play a critical role in accelerating India’s medical device manufacturing growth by enabling companies to meet stringent international standards domestically. The initiative is expected to support the broader goal of positioning the Yamuna Expressway region as a major global hub for medical technology manufacturing, research, and innovation.
